Carbonic anhydrase II mediates malignant behavior of pulmonary neuroendocrine tumors

American Journal of Respiratory Cell and Molecular Biology

Volumn 52, Issue 2, 2015, Pages 183-192

  Zhou, Yuanxiang ^a   Mokhtari, Reza Bayat ^a   Pan, Jie ^a   Cutz, Ernest ^a   Yeger, Herman ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Apoptosis; Carbonic anhydrase II; Clonogenicity; Tumor; Vascularization

Indexed keywords

CARBONATE DEHYDRATASE II; CASPASE 3; CASPASE 8; KI 67 ANTIGEN; MESSENGER RNA; SEROTONIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ANGIOGENESIS; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRONCHUS CARCINOID; CANCER INHIBITION; CLONOGENIC ASSAY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG TUMOR; MITOSIS INHIBITION; MOUSE; NEUROENDOCRINE TUMOR; NEUROSECRETORY CELL; NONHUMAN; PULMONARY NEUROENDOCRINE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL CELL LUNG CANCER; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; IMMUNOHISTOCHEMISTRY; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE;

APOPTOSIS; CARBONIC ANHYDRASE II; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG; LUNG NEOPLASMS; NEUROENDOCRINE TUMORS; RNA, SMALL INTERFERING; SEROTONIN;

EID: 84922235471     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2014-0054OC     Document Type: Article

References (41)

1. Gorshtein A, Gross DJ, Barak D, Strenov Y, Refaeli Y, Shimon I, Grozinsky-Glasberg S. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity. Cancer 2012;118:612-619.
2. Song H, Yao E, Lin C, Gacayan R, Chen MH, Chuang PT. Functional characterization of pulmonary neuroendocrine cells in lung development, injury, and tumorigenesis. Proc Natl Acad Sci USA 2012;109:17531-17536.
3. Kraus AC, Ferber I, Bachmann SO, Specht H, Wimmel A, Gross MW, Schlegel J, Suske G, Schuermann M. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene 2002;21:8683-8695.
4. Triller N, Korosec P, Kern I, Kosnik M, Debeljak A. Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease. Lung Cancer 2006;54:235-240.
5. Noel-Savina E, Descourt R. Focus on treatment of lung carcinoid tumor. Onco Targets Ther 2013;6:1533-1537.
6. Cutz E, Yeger H, Pan J. Pulmonary neuroendocrine cell system in pediatric lung disease-recent advances. Pediatr Dev Pathol 2007;10:419-435.
7. Domnik NJ, Cutz E. Pulmonary neuroepithelial bodies as airway sensors: putative role in the generation of dyspnea. Curr Opin Pharmacol 2011;11:211-217.
8. Fu XW, Nurse C, Cutz E. Characterization of slowly inactivating KVα current in rabbit pulmonary neuroepithelial bodies: effects of hypoxia and nicotine. Am J Physiol Lung Cell Mol Physiol 2007;293:L892-L902.
9. Cutz E, Pan J, Yeger H. The role of NOX2 and "novel oxidases" in airway chemoreceptor O(2) sensing. Adv Exp Med Biol 2009;648:427-438.
10. Chandrashekar J, Yarmolinsky D, von Buchholtz L, Oka Y, Sly W, Ryba NJ, Zuker CS. The taste of carbonation. Science 2009;326:443-445.
11. Frommer WB. Biochemistry. CO2mmon sense. Science 2010;327:275-276.
12. + sensing [abstract]. The XVIIIth Meeting of the International Society for Arterial Chemoreception, Hamilton, ON, Canada. 2011;38-39.
13. Pan J, Bear C, Farragher S, Cutz E, Yeger H. Cystic fibrosis transmembrane conductance regulator modulates neurosecretory function in pulmonary neuroendocrine cell-related tumor cell line models. Am J Respir Cell Mol Biol 2002;27:553-560.
14. Chiche J, Ilc K, Laferrière J, Trottier E, Dayan F, Mazure NM, Brahimi-Horn MC, Pouysségur J. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 2009;69:358-368.
15. Wolf MJ, Seleznik GM, Zeller N, Heikenwalder M. The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development. Oncogene 2010;29:5006-5018.
16. Swartz MA, Iida N, Roberts EW, Sangaletti S, Wong MH, Yull FE, Coussens LM, DeClerck YA. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res 2012;72:2473-2480.
17. Li X, Liu Y, Alvarez BV, Casey JR, Fliegel L. A novel carbonic anhydrase II binding site regulates NHE1 activity. Biochemistry 2006;45:2414-2424.
18. -transport can be rescued by carbonic anhydrase II presented on an adjacent AE1 protomer. J Biol Chem 2003;278:44949-44958.
19. 3 cotransporter NBCe1-A in Xenopus oocytes. J Biol Chem 2006;281:19241-19250.
20. Sterling D, Reithmeier RAF, Casey JR. A transport metabolon: functional interaction of carbonic anhydrase II and chloride/bicarbonate exchangers. J Biol Chem 2001;276:47886-47894.
21. Parks SK, Chiche J, Pouyssegur J. pH control mechanisms of tumor survival and growth. J Cell Physiol 2011;226:299-308.
22. Gatenby RA, Gillies RJ. A microenvironmental model of carcinogenesis. Nat Rev Cancer 2008;8:56-61.
23. Birner P, Jesch B, Friedrich J, Riegler M, Zacherl J, Hejna M, Wrba F, Schultheis A, Schoppmann SF. Carbonic anhydrase IX overexpression is associated with diminished prognosis in esophageal cancer and correlates with Her-2 expression. Ann Surg Oncol 2011;18:3330-3337.
24. Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, Kyle A, Auf dem Keller U, Leung S, Huntsman D, et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 2011;71:3364-3376.
25. Poulsen SA. Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007-2009. Expert Opin Ther Pat 2010;20:795-806.
26. McDonald PC, Winum J-Y, Supuran CT, Dedhar S. Recent developments in targeting carbonic anhydrase IX for cancer therapeutics. Oncotarget 2012;3:84-97.
27. Zhou R, Huang W, Yao Y, Wang Y, Li Z, Shao B, Zhong J, Tang M, Liang S, Zhao X, et al. CA II, a potential biomarker by proteomic analysis, exerts significant inhibitory effect on the growth of colorectal cancer cells. Int J Oncol 2013;43:611-621.
28. Liu LC, Xu WT, Wu X, Zhao P, Lv YL, Chen L. Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors. World J Gastroenterol 2013;19:2473-2480.
29. Liu CM, Lin YM, Yeh KT, Chen MK, Chang JH, Chen CJ, Chou MY, Yang SF, Chien MH. Expression of carbonic anhydrases I/II and the correlation to clinical aspects of oral squamous cell carcinoma analyzed using tissue microarray. J Oral Pathol Med 2012;41:533-539.
30. Parkkila S, Rajaniemi H, Parkkila AK, Kivela J, Waheed A, Pastorekova S, Pastorek J, Sly WS. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA 2000;97:2220-2224.
31. Takahashi M, Yang XJ, Sugimura J, Backdahl J, Tretiakova M, Qian CN, Gray SG, Knapp R, Anema J, Kahnoski R, et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 2003;22:6810-6818.
32. Haapasalo J, Nordfors K, Jörvelö S, Bragge H, Rantala I, Parkkila AK, Haapasalo H, Parkkila S. Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy. Neuro-oncol 2007;9:308-313.
33. Hynninen P, Parkkila S, Huhtala H, Pastorekova S, Pastorek J, Waheed A, Sly WS, Tomas E. Carbonic anhydrase isozymes II, IX, and XII in uterine tumors. APMIS 2012;120:117-129.
34. Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors - Part 94. 1,3,4-thiadiazole-2-sulfonamidederivatives as antitumor agents?Eur J Med Chem 2000;35:867-874.
35. Yoshiura K, Nakaoka T, Nishishita T, Sato K, Yamamoto A, Shimada S, Saida T, Kawakami Y, Takahashi TA, Fukuda H, et al. Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy. Clin Cancer Res 2005;11:8201-8207.
36. Mokhtari RB, Kumar S, Islam SS, Yazdanpanah M, Adeli K, Cutz E, Yeger H. Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines. BMC Cancer 2013;13:378-386.
37. Pan J, Copland I, Post M, Yeger H, Cutz E. Mechanical stretch-induced serotonin release from pulmonary neuroendocrine cells: implications for lung development. Am J Physiol Lung Cell Mol Physiol 2006;290:L185-L193.
38. Soll C, Jang JH, Riener MO, Moritz W, Wild PJ, Graf R, Clavien PA. 5-HT promotes tumor growth in human hepatocellular cancer. Hepatology 2010;51:244-254.
39. Drozdov I, Kidd M, Gustafsson BI, Svejda B, Joseph R, Pfragner R, Modlin IM. Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines. Cancer 2009;115:4934-4945.
40. Nocito A, Dahm F, Jochum W, Jang JH, Georgiev P, Bader M, Graf R, Clavien PA. Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts. Cancer Res 2008;68:5152-5158.
41. Huber V, De Milito A, Harguindey S, Reshkin SJ, Wahl ML, Rauch C, Chiesi A, Pouysségur J, Gatenby RA, Rivoltini L, et al. Proton dynamics in cancer. J Transl Med 2010;8:57-60.